Blog / Archives
Are Biotech M&A Premiums Already Built-In? Valuations Do Matter.
(Published this am in Seeking Alpha) Onyx Pharmaceuticals (ONXX) $10.4B Buy-Out Fuels Speculative Deal Lists We have written extensively on the life science bull market and its underpinnings: cheap...
Stocks Snap-Back After Sell-Off: NASDAQ Up 0.55%, ASTX Soars
But Uncertainty Clouds Intermediate Term Economic Outlook: Oil prices, Emerging Markets, Russia and the FED Concerns about another Middle East war and a spike in oil prices waned a bit today but...
Rayno Life Science Stocks: Deals Propel AMGN RGDX
Life science stocks resumed their upward trajectory today with major ETFs (FBT,IBB,XBI) up over 2% and a green screen for the sector. Mid-cap biopharma stocks are strong once again. The IBB hit an...
NASDAQ Trades Halted on All Stocks 2 Hour Lockdown on NASDAQ Update
Update 8/26 Best idea on securities exchanges: Randall W.Forsyth in his Barron's Up and Down Wall Street column recommends that the NASDAQ and NYSE are put under the watchful eye of the NSA. And...
Biotechs Rally After FED Minutes-Sharp Comeback Update—- after close
Very Strange Whipsaw Day Who is in charge of this market, humans or computers? Earlier: My biopharma screen has gone green. Maybe "taper light" scenario means buy biotech as macro and...
Pure Play Diagnostic Companies-Metrics After Q2 Earnings: ALR, QDEL and TMO
Diagnostics Company Stocks Are Off Their 2013 Highs Life science tools and diagnostics stocks are near all time highs despite stretched valuations because of a strong secular biotech bull market and...
Pivotal Week Coming Up For Stocks: Can Technicals Hold With Little News?
Tempering, Tapering and Transition A mild sell-off shifted momentum to the bears last week as countercurrents and seasonality comes into play. Heavy vacations in August transition to Labor Day...
Risk Off Resumes With Profit Taking-Biotechs Off 5% From Highs
Biotech Sector Momentum Quits-IBB at Support Level of $189 NASDAQ Off 1.73% to 3605 Have fund managers raised cash and gone on vacation? Moreover many weaker sectors have become leaders like gold,...
Rayno Life Science Portfolio: ILMN, PCYC, RGDX
Market Can't Stay Down in Quiet Trading After a couple of lackluster trading days the market perked up as economic news continues positive with retail sales up for the fourth consecutive month and...
Mixed Day Except Intrexon (XON) IPO Soars 54%
Intrexon (XON), a synthetic biology Company, focused in healthcare, animal science and agriculture raised over $160M in a Huge IPO . CEO Randall Kirk purchased 30M shares. Some pundits say this...